The Evolution of Ad Targeting and Healthcare Marketing: Insights from Jeff Greenfield

In the latest episode of the Health Biz Podcast, Jeff Greenfield, co-founder and CEO of Provalytics, offers a deep dive into the complex world of advertising technology and healthcare marketing. Greenfield shares his expertise on how advancements in AI and data analytics are transforming the way ads are targeted and how the pharmaceutical industry navigates this landscape.

The Impact of AI and Personalization on Ad Costs

Greenfield highlights the sophistication of modern digital advertising, where AI allows for near real-time ad personalization. While this targeted approach enhances user engagement, it significantly increases the cost of delivering ads. Greenfield shares a case study from years ago involving a weight loss client, where using Mastercard data to target competitors’ customers led to a tenfold increase in ad costs. Despite acquiring new customers, the return on investment was negative due to high delivery costs.

🚀 Yes, I Want The 2026 Playbook!


The State of Healthcare and Pharma Marketing

Digital marketing has dramatically transformed how healthcare and pharmaceutical companies reach audiences. Historically reliant on traditional media like TV and radio, these industries now leverage digital platforms for more precise targeting. The goal is to educate consumers about new treatments and encourage them to discuss options with their healthcare providers. The integration of digital marketing with traditional media aims to maximize outreach and effectiveness.

Privacy Concerns and the Future of Cookies

Greenfield discusses the evolving landscape of privacy and its impact on digital marketing. Apple’s iOS updates and browser changes have shifted how user data is tracked, challenging the use of third-party cookies. While Google has delayed phasing out cookies, their effectiveness has waned, and user preferences are shifting towards enhanced privacy. This transition raises questions about how future tracking will adapt to these changes.

Provalytics’ Approach to Data and Analytics

Provalytics stands out by offering solutions that avoid the pitfalls of traditional cookie-based tracking. The company uses aggregated, anonymized data from ad platforms, employing advanced statistical techniques to connect advertising efforts to actual outcomes, like prescription rates. This approach enables more accurate measurement without compromising user privacy.

Greenfield’s Personal Journey and Recommendations

Reflecting on his career, Greenfield contrasts the creative aspirations of marketers with the data-driven reality of modern advertising. Provalytics helps bridge this gap by simplifying complex data analysis, allowing marketers to focus on creativity. Greenfield also recommends “Black Elk Speaks,” a compelling book on Native American history and culture.

For a deeper dive into these topics and more insights from Jeff Greenfield, listen to the full episode of the Health Biz Podcast.

2026 Attribution Playbook

The 2026 Attribution Playbook is a must-have guide for marketers navigating the evolution of attribution.

This year’s edition (available as a free download here ) explores how to tackle multi-touch attribution amid emerging privacy challenges.

Prepare for the cookieless future today.

This vital resource equips organizations with insights to craft smarter strategies, achieve marketing goals, and drive measurable ROI.

👉 Download your copy of the Attribution Playbook now.